Scientists track immune cells to unlock immunotherapy secrets in kidney and bladder cancers

NCT ID NCT02978118

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how immune cells change in the blood of people with kidney or bladder cancer during immunotherapy treatment. Researchers will measure different immune cells and tumor cells in blood samples from 67 participants. The goal is to better understand how the immune system responds to these treatments, not to test a new therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors predict which patients respond best to immunotherapy for kidney and bladder cancers.

What could go wrong

This is a small pilot study focused on observation, not treatment. It may not lead to immediate changes in patient care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, RENAL CELL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma renal cell adenocarcinoma renal cell carcinoma urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States